David Dobrowski, n/a

VP Clinical Development & Regulatory Affairs
ABK Biomedical Inc.

Presentation(s):

• Initial Clinical Experience with a Novel Glass Radiopaque Yttrium-90 Radioembolization Microsphere for Treating Malignant Liver Tumors

  Wednesday, March 8, 2023
  3:54 PM – 4:03 PM

  Disclosure information not submitted.